Contributed Equity (Tables)

12 Months Ended

Jun. 30, 2025

Statements [Line Items]

Summary of Contributed Equity

			Consolidated
	Note		June 30, 2025 A$		June 30, 2024 A$
Fully paid ordinary shares		21(a)		535,069,876		532,443,233
Options over ordinary shares – listed				9,661,954		9,661,954
				544,731,830		542,105,187

Summary of Ordinary Shares

(a) Ordinary Shares

			June 30, 2025				June 30, 2024
	Note		No.		A$		No.		A$
At the beginning of reporting period				1,452,612,290		532,443,233		1,187,306,209		436,610,249
Shares issued during the year		21(b)		—		—		263,777,731		100,235,538
Transaction costs relating to share issues				—		—		—		(4,841,655	)
Exercise of performance rights (shares issued during the year)		21(b)		7,777,285		2,626,643		1,528,350		439,101
Conversion of Convertible Notes (shares issued during the period)				—		—		—		—
At reporting date				1,460,389,575		535,069,876		1,452,612,290		532,443,233

Summary of Shares Issued

(b) Shares issued

2025 Details	Number		Issue Price A$		Total A$
Performance rights exercised (transfer from share-based payment reserve)		7,777,285		0.34		2,626,643
		7,777,285				2,626,643

2024 Details	Number		Issue Price A$		Total A$
Share issued under Retail Entitlement Offer		28,063,871		0.38		10,664,271
Shares issued under Institutional Placement		235,713,860		0.38		89,571,267
Performance rights exercised (transfer from share-based payment reserve)		1,528,350		0.29		439,101
		265,306,081				100,674,639

Summary of Unlisted Options

Unlisted Options

Expiration Date	Exercise Price		Number
August 4, 2025	$	0.24		847,600
Total				847,600